Efficacy of Targeted Therapies in Metastatic Colorectal Cancer: Meta-Analysis

被引：0
|
作者：
Gouverneur, Amandine [1 ]
Arnaud, Mickael [2 ]
Berdai, Driss [3 ]
DeBoissieu, Paul [4 ]
Fourrier-Reglat, Annie [1 ]
Noize, Pernelle [4 ]
Salvo, Francesco [1 ]
机构：
[1] Univ Bordeaux, CHU Bordeaux, Inserm U1219, Pharmacol Med, Bordeaux, France
[2] Univ Bordeaux, Inserm U1219, Bordeaux, France
[3] CHU Bor Bordeaux, Pharmacol Med, Bordeaux, France
[4] CHU Bordeaux, Pharmacol Med, Inserm U1219, Bordeaux, France
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2017年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
602
引用
收藏
页码：363 / 364
页数：2
相关论文
共 50 条
  • [1] Efficacy of targeted therapies metastatic colorectal cancer: systematic review and meta-analysis
    Gouverneur, A.
    Arnaud, M.
    Berdai, D.
    De Boissieu, P.
    Fourrier-Reglat, A.
    Noize, P.
    Salvo, F.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2017, 31 : 8 - 8
  • [2] Strategies of sequential therapies in unresectable metastatic colorectal cancer: a meta-analysis
    Asmis, T.
    Berry, S.
    Cosby, R.
    Chan, K.
    Coburn, N.
    Rother, M.
    [J]. CURRENT ONCOLOGY, 2014, 21 (06) : 318 - 328
  • [3] The efficacy of panitumumab in refractory metastatic colorectal cancer: A meta-analysis
    Duan, Kun-Feng
    Wang, Hua
    [J]. JOURNAL OF BUON, 2019, 24 (04): : 1457 - 1463
  • [4] A meta-analysis of safety and efficacy of regorafenib for refractory metastatic colorectal cancer
    Xue, Wu-Song
    Men, Si-Ye
    Liu, Wei
    Liu, Reng-Hai
    [J]. MEDICINE, 2018, 97 (40)
  • [5] Comparative efficacy of later-line therapies for metastatic colorectal cancer: a network meta-analysis of survival curves
    Obeng-Kusi, Mavis
    Martin, Jennifer R.
    Roe, Denise
    Erstad, Brian L.
    Abraham, Ivo
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2024, 24 (08) : 923 - 932
  • [6] A network meta-analysis on the efficacy of sixteen targeted drugs in combination with chemotherapy for treatment of advanced/metastatic colorectal cancer
    Ba-Sang, Dan-Zeng
    Long, Zi-Wen
    Teng, Hao
    Zhao, Xu-Peng
    Qiu, Jian
    Li, Ming-Shan
    [J]. ONCOTARGET, 2016, 7 (51) : 84468 - 84479
  • [7] IMPACT OF CHEMOTHERAPY PARTNER ON EFFICACY OF TARGETED AGENTS IN METASTATIC COLORECTAL CANCER (MCRC): SYSTEMATIC REVIEW AND META-ANALYSIS
    Chan, David
    Pavlakis, Nick
    Shapiro, Jeremy
    Price, Timothy
    Karapetis, Chris
    Tebbutt, Niall
    Segelov, Eva
    [J]. ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 104 - 104
  • [8] Comparative Efficacy and safety of new targeted therapies and immunotherapies for metastatic triple negative breast cancer: a network meta-analysis
    Leung, John Hang
    Tai, Yun-Sheng
    Wang, Shyh-Yau
    Tsung-Chin, Ho
    Yip Fion, Hei-Tung
    Chan, Agnes L. F.
    Yu-Chen, Hsu
    [J]. EXPERT OPINION ON DRUG SAFETY, 2023, 22 (03) : 243 - 252
  • [9] Targeted first-line therapies for advanced colorectal cancer: a Bayesian meta-analysis
    Ridouane, Yassine
    Lopes, Gilberto
    Ku, Geoffrey
    Masud, Hasan
    Haaland, Benjamin
    [J]. ONCOTARGET, 2017, 8 (39) : 66458 - 66466
  • [10] Does the Chemotherapy Backbone Impact on the Efficacy of Targeted Agents in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis of the Literature
    Chan, David L.
    Pavlakis, Nick
    Shapiro, Jeremy
    Price, Timothy J.
    Karapetis, Christos S.
    Tebbutt, Niall C.
    Segelov, Eva
    [J]. PLOS ONE, 2015, 10 (08):
12345